237 related articles for article (PubMed ID: 22035752)
1. Fludarabine versus chlorambucil: is the debate over?
Rai KR; Hollweg A
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S7-9. PubMed ID: 22035752
[TBL] [Abstract][Full Text] [Related]
2. Fludarabine: new indication. First-line treatment of CLL: unconvincing evidence.
Prescrire Int; 2005 Feb; 14(75):3-5. PubMed ID: 15747447
[TBL] [Abstract][Full Text] [Related]
3. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
[TBL] [Abstract][Full Text] [Related]
5. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia.
Robak T; Kasznicki M
Leukemia; 2002 Jun; 16(6):1015-27. PubMed ID: 12040433
[TBL] [Abstract][Full Text] [Related]
6. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
7. Chronic lymphocytic leukemia in the elderly population.
Rai KR
Clin Geriatr Med; 1997 May; 13(2):245-9. PubMed ID: 9115449
[TBL] [Abstract][Full Text] [Related]
8. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
Robak T
Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
[TBL] [Abstract][Full Text] [Related]
9. Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Mulligan SP; Karlsson K; Strömberg M; Jønsson V; Gill D; Hammerström J; Hertzberg M; McLennan R; Uggla B; Norman J; Wallvik J; Sundström G; Johansson H; Brandberg Y; Liliemark J; Juliusson G;
Leuk Lymphoma; 2014 Dec; 55(12):2769-77. PubMed ID: 24524339
[TBL] [Abstract][Full Text] [Related]
10. First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia.
Eichhorst BF; Busch R; Stilgenbauer S; Stauch M; Bergmann MA; Ritgen M; Kranzhöfer N; Rohrberg R; Söling U; Burkhard O; Westermann A; Goede V; Schweighofer CD; Fischer K; Fink AM; Wendtner CM; Brittinger G; Döhner H; Emmerich B; Hallek M;
Blood; 2009 Oct; 114(16):3382-91. PubMed ID: 19605849
[TBL] [Abstract][Full Text] [Related]
11. High dose chlorambucil in the treatment of lymphoid malignancies.
Nicolle A; Proctor SJ; Summerfield GP
Leuk Lymphoma; 2004 Feb; 45(2):271-5. PubMed ID: 15101711
[TBL] [Abstract][Full Text] [Related]
12. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
[TBL] [Abstract][Full Text] [Related]
14. Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison.
Van Sanden S; Baculea S; Diels J; Cote S
Adv Ther; 2017 Jul; 34(7):1650-1661. PubMed ID: 28573505
[TBL] [Abstract][Full Text] [Related]
15. Results of a randomized trial of chlorambucil versus fludarabine for patients with untreated Waldenström macroglobulinemia, marginal zone lymphoma, or lymphoplasmacytic lymphoma.
Leblond V; Johnson S; Chevret S; Copplestone A; Rule S; Tournilhac O; Seymour JF; Patmore RD; Wright D; Morel P; Dilhuydy MS; Willoughby S; Dartigeas C; Malphettes M; Royer B; Ewings M; Pratt G; Lejeune J; Nguyen-Khac F; Choquet S; Owen RG
J Clin Oncol; 2013 Jan; 31(3):301-7. PubMed ID: 23233721
[TBL] [Abstract][Full Text] [Related]
16. The long-term outcome of patients in the LRF CLL4 trial: the effect of salvage treatment and biological markers in those surviving 10 years.
Else M; Wade R; Oscier D; Catovsky D
Br J Haematol; 2016 Jan; 172(2):228-37. PubMed ID: 26457986
[TBL] [Abstract][Full Text] [Related]
17. Fludarabine for chronic lymphocytic leukemia.
Erman M; Celik I; Tekuzman G
N Engl J Med; 2001 Apr; 344(15):1166; author reply 1167-8. PubMed ID: 11302142
[No Abstract] [Full Text] [Related]
18. [Long-term results with fludarabine monotherapy in chronic lymphocytic leukemia].
Varga F; Lehoczky D; Demeter J
Orv Hetil; 1999 Aug; 140(31):1731-5. PubMed ID: 10463032
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.
Richards S
Cancer Treat Rev; 2005 Jun; 31(4):332-5. PubMed ID: 15894429
[No Abstract] [Full Text] [Related]
20. A phase I study of imatinib mesylate in combination with chlorambucil in previously treated chronic lymphocytic leukemia patients.
Hebb J; Assouline S; Rousseau C; Desjardins P; Caplan S; Egorin MJ; Amrein L; Aloyz R; Panasci L
Cancer Chemother Pharmacol; 2011 Sep; 68(3):643-51. PubMed ID: 21120481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
